Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity

[1]  Andrew S. Felts,et al.  Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity, and Agonism: Enriching Structure-Function Studies and Structure-Activity Relationships , 2012, Molecular Pharmacology.

[2]  Min Goo Lee,et al.  Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function , 2012, Nature.

[3]  H. Lavreysen,et al.  Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function , 2012, Molecular Pharmacology.

[4]  Mark F. Bear,et al.  Mutations causing syndromic autism define an axis of synaptic pathophysiology , 2011, Nature.

[5]  S. Stauffer,et al.  Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). , 2011, ACS chemical neuroscience.

[6]  Jeffrey S. Smith,et al.  Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator. , 2011, European journal of pharmacology.

[7]  P Jeffrey Conn,et al.  "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology. , 2011, Biochemistry.

[8]  C. Lindsley,et al.  Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold. , 2011, Bioorganic & medicinal chemistry letters.

[9]  Mark F Bear,et al.  Toward fulfilling the promise of molecular medicine in fragile X syndrome. , 2011, Annual review of medicine.

[10]  P Jeffrey Conn,et al.  Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity , 2010, Molecular Pharmacology.

[11]  R. Wong,et al.  Cellular Plasticity for Group I mGluR-Mediated Epileptogenesis , 2009, The Journal of Neuroscience.

[12]  P. Wellendorph,et al.  Molecular basis for amino acid sensing by family C G‐protein‐coupled receptors , 2009, British journal of pharmacology.

[13]  B Greger,et al.  A Simple Quantitative Method for Analyzing Electrographic Status Epilepticus in Rats Electrode Implantation , 2022 .

[14]  M. Foster Olive,et al.  mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning , 2009, Neuropsychopharmacology.

[15]  F. Liu,et al.  ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities , 2008, Journal of Pharmacology and Experimental Therapeutics.

[16]  B. Moghaddam,et al.  Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. , 2008, Behavioural pharmacology.

[17]  P. Jeffrey Conn,et al.  N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) Acts through a Novel Site as a Positive Allosteric Modulator of Group 1 Metabotropic Glutamate Receptors , 2008, Molecular Pharmacology.

[18]  J. Pin,et al.  Interaction of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 with the Negative Allosteric Antagonist Site Is Required for Potentiation of Receptor Responses , 2007, Molecular Pharmacology.

[19]  P. Jeffrey Conn,et al.  A Close Structural Analog of 2-Methyl-6-(phenylethynyl)-pyridine Acts as a Neutral Allosteric Site Ligand on Metabotropic Glutamate Receptor Subtype 5 and Blocks the Effects of Multiple Allosteric Modulators , 2005, Molecular Pharmacology.

[20]  C. Lindsley,et al.  A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models , 2005, Journal of Pharmacology and Experimental Therapeutics.

[21]  R. Wong,et al.  Group I mGluR-induced Epileptogenesis: Distinct and Overlapping Roles of mGluR1 and mGluR5 and Implications for Antiepileptic Drug Design , 2005, Epilepsy currents.

[22]  R. Wong,et al.  Extracellular Signal-regulated Kinase 1/2 Is Required for the Induction of Group I Metabotropic Glutamate Receptor- Mediated Epileptiform Discharges Transient Stimulation of Group I Metabotropic Glutamate Receptors (mglurs) Induces Persistent Prolonged Epileptiform Discharges in Hippocampal Slices v , 2022 .

[23]  Mark Washburn,et al.  3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. , 2003, Journal of medicinal chemistry.

[24]  F. Gasparini,et al.  The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors* , 2000, The Journal of Biological Chemistry.

[25]  P. Bergold,et al.  Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. , 1998, Journal of neurophysiology.

[26]  D. Schoepp,et al.  Receptor Subtypes Linked to Metabotropic Glutamate Receptor Agonist‐Mediated Limbic Seizures in Mice , 1995, Annals of the New York Academy of Sciences.

[27]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[28]  S. Jadhav,et al.  Allosteric Modulators of Metabotropic Glutamate Receptor 5 for Treatment of Schizophrenia , 2011 .

[29]  Arthur Christopoulos,et al.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders , 2009, Nature Reviews Drug Discovery.

[30]  Craig W Lindsley,et al.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. , 2009, Trends in pharmacological sciences.

[31]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[32]  R. Racine.  Modification of seizure activity by electrical stimulation: cortical areas. , 1975, Electroencephalography and clinical neurophysiology.